# Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery

> **NCT01079793** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** ixabepilone
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT01079793
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-05-26
- **Primary completion:** 2011-10-17
- **Final completion:** 2011-10-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Overlapping study, PI preferred to enroll in alternate trial.
- **Last updated:** 2020-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01079793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01079793, "Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01079793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*